About Tirzepatide
Tirzepatide (development code LY3298176) is a synthetic 39-amino-acid peptide modified with a C20 fatty diacid side chain. It acts as an agonist at two incretin hormone receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It has the molecular formula C225H348N48O68 and a molecular weight of approximately 4813.5 g/mol.
Tirzepatide is also the active ingredient in licensed prescription medicines. The product sold here is a research compound for laboratory use only. It is not a medicine and is not for human use.
Related research compounds: Semaglutide (GLP-1 receptor), Retatrutide (GIP, GLP-1 and glucagon receptors) and Cagrilintide (an amylin analogue).
Areas of research
Tirzepatide is one of the most extensively studied dual-receptor peptides. Published research includes:
- pharmacology studies in cells describing how it activates the GIP and GLP-1 receptors differently, sometimes described as “imbalanced” and “biased” agonism [1]
- structural studies of how it binds to and activates the GIP and GLP-1 receptors [2, 3]
- cell and mouse studies of how it acts on adipocyte nutrient metabolism through the GIP receptor [4]
These studies relate to tirzepatide as a pharmaceutical substance studied under controlled conditions. They are cited here for scientific background only.
Product specifications
| Form |
Lyophilised (freeze-dried) powder in a sealed vial |
| Sizes |
2mg, 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg |
| Structure |
39-amino-acid peptide with a C20 fatty diacid side chain |
| Molecular formula |
C225H348N48O68 |
| Molecular weight |
approx. 4813.5 g/mol |
| Purity |
Where your size has no COA of its own, the COA shown is for another batch size. Current COAs for the 10mg, 20mg, 30mg, 40mg and 60mg sizes report HPLC purity above 99.5%. |
Storage and handling
Storage & Handling — Corex Vitality™ research vials
- As supplied: freeze-dried (lyophilised) powder in a sealed vial. Room-temperature transit is normal for dry peptides.
- Longer storage: keep the vial tightly closed in a freezer at −20 °C or colder, dry and away from light. Colder is better for long archives.
- Short-term: a laboratory fridge (2–8 °C) is fine for vials you plan to open soon.
- Before opening: let the closed vial warm to room temperature, ideally in a desiccator, so moisture does not condense on the powder. Work quickly and reseal tightly; absorbed moisture lowers the real peptide content.
- Dissolving: choose a solvent based on the sequence (see the compound note below) and test a small portion first. Swirl gently; brief sonication in a water bath can help. Do not heat.
- Once in solution: make up only what you need. Split any solution you keep into single-use aliquots, freeze at −20 °C or colder and thaw each aliquot only once. Peptides keep far less well in solution than as dry powder.
- Safety: handle in a suitable laboratory with appropriate PPE, following your institution’s safety procedures, and avoid breathing the powder. Keep out of reach of children.
Compound note: Oxidation-sensitive: lipidated, overall acidic peptide containing tryptophan. If slow in water, a neutral-to-slightly-basic buffer (e.g. PBS up to about 1 mg/mL, or a trace of dilute aqueous ammonia then dilution) is the usual route. Protect from light; degassed solvent preferred.
For in-vitro laboratory research use only. Not for human or veterinary use. General guidance paraphrased from Bachem: Handling and Storage Guidelines for Peptides and Peptide Solubility.
Quality and testing
Tirzepatide batches we sell have a published third-party HPLC Certificate of Analysis. On Lingda reports the Client is the manufacturer/supplier; we publish the file exactly as issued. COAs have been issued for the 10mg, 20mg, 30mg, 40mg and 60mg batches; for other sizes, the COA shown is for one of those batches of the same compound. You can also browse every published certificate on our COA and verification page.
Research use only
For in-vitro laboratory research use only. Not for human or veterinary use. These products are research chemicals. They are not medicines, food, or supplements. They have not been evaluated by the MHRA, FDA, or any other regulatory body. Not intended to diagnose, treat, cure, or prevent any disease. All descriptions are for reference and research documentation purposes only. By purchasing, you confirm you are aged 18+ and using these products exclusively for in vitro laboratory research.
Related reading
References
- Willard FS, et al. Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight. 2020. PubMed 32730231
- Zhao F, et al. Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors. Nat Commun. 2022. PubMed 35217653
- Sun B, et al. Structural determinants of dual incretin receptor agonism by tirzepatide. Proc Natl Acad Sci U S A. 2022. PubMed 35333651
- Regmi A, et al. Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor. Cell Metab. 2024. PubMed 38878772
Reviews
There are no reviews yet.